C
CNTX
Context Therapeutics Inc
0.5040
-0.1890-27.27%Pre Market: 0.4998 -0.0042 -0.83%09:15 08/07 EDT
OPEN/PREV CLOSE0.5049/0.6930
TODAY RANGE0.4900-0.5399
VOL26.49K
MARKET CAP46.31M
52 WEEK RANGE0.4900-3.620
AVG VOL (3M)2.45M
% TURNOVER4.72%
TURNOVER0
P/E (TTM)-1.1929
% RANGE7.20%
EPS(TTM)-0.4225
P/E(FORWARD)-1.2293
P/B0.8870
BVPS0.5682
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP45.68M
SHARES OUTSTANDING91.88M
NEXT EARNINGS11/02-11/06
FREE FLOAT90.63M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·15h ago
LifeSci Capital downgrades Context Therapeutics (CNTX) to a Hold
Reuters·1d ago
Whitehawk Therapeutics Q2 net loss narrows
Reuters·1d ago
CORRECTED-Switzerland's Roivant Q1 loss widens
Reuters·1d ago
Switzerland's Roivant Q1 loss widens
Reuters·1d ago
Immunovant Q1 net loss widens
Reuters·1d ago
Sionna Therapeutics Q2 net loss widens
Seeking Alpha·1d ago
Context Therapeutics GAAP EPS of -$0.15
TipRanks·1d ago
Context Therapeutics reports Q2 EPS (15c), consensus (9c)
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.